Savara (SVRA) News Today $3.01 +0.08 (+2.73%) Closing price 04/17/2025 04:00 PM EasternExtended Trading$3.00 -0.01 (-0.33%) As of 04/17/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Savara (NASDAQ:SVRA) Shares Up 4.1% - Here's What HappenedSavara (NASDAQ:SVRA) Shares Up 4.1% - Still a Buy?April 17 at 2:14 PM | marketbeat.comAffinity Asset Advisors LLC Lowers Stock Position in Savara Inc (NASDAQ:SVRA)Affinity Asset Advisors LLC reduced its position in Savara Inc (NASDAQ:SVRA - Free Report) by 41.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 410,586 shares of the company's stock after selling 289,414 shares during the qApril 17 at 7:52 AM | marketbeat.comSavara Inc. Announces Equity Awards for New EmployeesApril 16 at 1:30 PM | msn.comSavara Inc (NASDAQ:SVRA) Shares Purchased by Vanguard Group Inc.Vanguard Group Inc. increased its stake in shares of Savara Inc (NASDAQ:SVRA - Free Report) by 4.6% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 8,309,970 shares of the company's stock after purchasing an additional 365,959 shares during the period. VaApril 16 at 3:19 AM | marketbeat.comSavara Inc (NASDAQ:SVRA) Receives Average Rating of "Moderate Buy" from BrokeragesSavara Inc (NASDAQ:SVRA - Get Free Report) has received an average rating of "Moderate Buy" from the six analysts that are presently covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the compApril 13, 2025 | marketbeat.comSavara Announces New Employment Inducement GrantApril 11, 2025 | businesswire.comWellington Management Group LLP Lowers Stock Holdings in Savara Inc (NASDAQ:SVRA)Wellington Management Group LLP lessened its stake in shares of Savara Inc (NASDAQ:SVRA - Free Report) by 36.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,481,654 shares of the compApril 11, 2025 | marketbeat.comSavara Inc (NASDAQ:SVRA) Shares Purchased by ADAR1 Capital Management LLCADAR1 Capital Management LLC grew its holdings in shares of Savara Inc (NASDAQ:SVRA - Free Report) by 33.1% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 988,468 shares of the company's stock after purchasing an additional 245,834 shares duringApril 9, 2025 | marketbeat.comSavara announces encore presentations from Molgramostim Phase 3 IMPALA-2 trialApril 8, 2025 | markets.businessinsider.comSavara Announces Encore Presentations From the Phase 3 IMPALA-2 Trial of Molgramostim Inhalation Solution (Molgramostim) in Patients With Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at Two Upcoming Scientific ConferencesApril 7, 2025 | businesswire.com259,798 Shares in Savara Inc (NASDAQ:SVRA) Bought by Raymond James Financial Inc.Raymond James Financial Inc. purchased a new stake in Savara Inc (NASDAQ:SVRA - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 259,798 shares of the company's stock, valued at approximately $7April 7, 2025 | marketbeat.comTuesday 4/1 Insider Buying Report: NTAP, SVRAApril 4, 2025 | nasdaq.comSAVARA Earnings Preview: Recent $SVRA Insider Trading, Hedge Fund Activity, and MoreApril 2, 2025 | nasdaq.comEvercore ISI Keeps Their Hold Rating on Savara (SVRA)April 1, 2025 | markets.businessinsider.comSavara Reports 2024 Financial Results and Provides Updates on MOLBREEVI ProgressApril 1, 2025 | msn.comWhat is HC Wainwright's Estimate for Savara Q1 Earnings?Savara Inc (NASDAQ:SVRA - Free Report) - Analysts at HC Wainwright issued their Q1 2025 earnings per share estimates for Savara in a research report issued to clients and investors on Friday, March 28th. HC Wainwright analyst A. Fein expects that the company will earn ($0.13) per share for the quMarch 31, 2025 | marketbeat.comSavara (NASDAQ:SVRA) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPSSavara (NASDAQ:SVRA - Get Free Report) posted its earnings results on Thursday. The company reported ($0.13) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.02). The business had revenue of $0.27 million during the quarter.March 29, 2025 | marketbeat.comSavara's (SVRA) "Buy" Rating Reiterated at HC WainwrightHC Wainwright restated a "buy" rating and set a $6.00 price objective on shares of Savara in a report on Friday.March 29, 2025 | marketbeat.comSavara submits FDA application for aPAP therapy MOLBREEVIMarch 29, 2025 | uk.investing.comAnalysts Conflicted on These Healthcare Names: Savara (SVRA) and Zentalis Pharmaceuticals (ZNTL)March 28, 2025 | markets.businessinsider.comSavara reports Q4 EPS (13c), consensus (11c)March 27, 2025 | markets.businessinsider.comSavara completes BLA submission to FDA for MolbreeviMarch 27, 2025 | markets.businessinsider.comSavara Reports Fourth Quarter and Year End 2024 Financial Results and Provides Business UpdateMarch 27, 2025 | businesswire.comSavara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules CapitalMarch 26, 2025 | businesswire.comSavara Completes Submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a Treatment for Autoimmune Pulmonary Alveolar Proteinosis (aPAP)March 26, 2025 | businesswire.comSavara Mudigi Moved after Leading National Anthem Before Kenya vs Gabon MatchMarch 25, 2025 | msn.comEmerald Advisers LLC Acquires Shares of 2,332,680 Savara Inc (NASDAQ:SVRA)Emerald Advisers LLC bought a new position in Savara Inc (NASDAQ:SVRA - Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The fund bought 2,332,680 shares of the company's stock, valued at approximately $7,161,000. Emerald Advisers LLC owned about 1.36% oMarch 24, 2025 | marketbeat.comVictory Capital Management Inc. Reduces Stock Holdings in Savara Inc (NASDAQ:SVRA)Victory Capital Management Inc. decreased its position in Savara Inc (NASDAQ:SVRA - Free Report) by 92.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 11,246 shares of the company's stock after selling 128March 24, 2025 | marketbeat.com2,654,944 Shares in Savara Inc (NASDAQ:SVRA) Acquired by Rosalind Advisors Inc.Rosalind Advisors Inc. bought a new position in shares of Savara Inc (NASDAQ:SVRA - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 2,654,944 shares of the company's stock, vMarch 23, 2025 | marketbeat.comSavara Inc (NASDAQ:SVRA) Holdings Raised by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. boosted its holdings in Savara Inc (NASDAQ:SVRA - Free Report) by 21.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 837,467 shares of the company'sMarch 18, 2025 | marketbeat.comSavara Inc (NASDAQ:SVRA) Given Consensus Rating of "Moderate Buy" by BrokeragesSavara Inc (NASDAQ:SVRA - Get Free Report) has received a consensus recommendation of "Moderate Buy" from the six research firms that are presently covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have given a buy rating tMarch 17, 2025 | marketbeat.comSavara Inc. Launches Convenient DBS Test for Diagnosing Rare Lung DiseaseMarch 11, 2025 | msn.comSavara Inc. to Present at Leerink Global Healthcare ConferenceMarch 10, 2025 | msn.comOppenheimer & Co. Inc. Decreases Stock Holdings in Savara Inc (NASDAQ:SVRA)Oppenheimer & Co. Inc. lessened its holdings in Savara Inc (NASDAQ:SVRA - Free Report) by 86.5% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 15,600 shares of the company's stock after selling 100,004 sharesMarch 10, 2025 | marketbeat.comSavara Launches New Dried Blood Spot Test For APAP DiagnosisMarch 9, 2025 | nasdaq.comSauti Soul’s Savara Narrates Hilarious Experience after Getting Arrested in Tanzania: "Tulikamatwa"March 4, 2025 | msn.comSavara Announces Participation in the Leerink Global Healthcare ConferenceMarch 3, 2025 | finance.yahoo.comSavara (SVRA) Expected to Announce Earnings on ThursdaySavara (NASDAQ:SVRA) will be releasing earnings before the market opens on Thursday, March 6, Financial Modeling Prep reports.February 27, 2025 | marketbeat.comSavara Inc (NASDAQ:SVRA) Given Average Recommendation of "Moderate Buy" by BrokeragesSavara Inc (NASDAQ:SVRA - Get Free Report) has received an average recommendation of "Moderate Buy" from the seven brokerages that are currently covering the firm, MarketBeat reports. One investment analyst has rated the stock with a hold recommendation and six have given a buy recommendation toFebruary 20, 2025 | marketbeat.comSavara Announces New Employment Inducement GrantFebruary 14, 2025 | businesswire.comPositive Signs As Multiple Insiders Buy Savara StockFebruary 8, 2025 | finance.yahoo.comSavara’s Molgramostim: Strong Buy Rating Backed by Clinical and Real-World Evidence for aPAP TreatmentJanuary 30, 2025 | markets.businessinsider.comSVRA stock touches 52-week low at $2.6 amid market challengesJanuary 30, 2025 | msn.comMolgramostim shows promise in rare lung disease treatmentJanuary 30, 2025 | msn.comSavara Announces Manuscript on Long-Term Outcomes With Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) Published in ERJ Open ResearchJanuary 30, 2025 | businesswire.comSavara Inc (NASDAQ:SVRA) Receives Consensus Rating of "Moderate Buy" from AnalystsSavara Inc (NASDAQ:SVRA - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are currently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to tJanuary 26, 2025 | marketbeat.comSavara sets executive bonus targets for 2025January 24, 2025 | msn.comSavara (NASDAQ:SVRA) Stock Price Down 5.3% - Here's What HappenedSavara (NASDAQ:SVRA) Shares Down 5.3% - What's Next?January 16, 2025 | marketbeat.comSavara (NASDAQ:SVRA) Shares Up 8.1% - Should You Buy?Savara (NASDAQ:SVRA) Stock Price Up 8.1% - Should You Buy?January 15, 2025 | marketbeat.comSavara Inc (NASDAQ:SVRA) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Savara Inc (NASDAQ:SVRA - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the seven analysts that are currently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have issued a buy recommendJanuary 1, 2025 | marketbeat.com Get Savara News Delivered to You Automatically Sign up to receive the latest news and ratings for SVRA and its competitors with MarketBeat's FREE daily newsletter. Email Address SVRA Media Mentions By Week SVRA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SVRA News Sentiment▼1.170.49▲Average Medical News Sentiment SVRA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SVRA Articles This Week▼73▲SVRA Articles Average Week Get Savara News Delivered to You Automatically Sign up to receive the latest news and ratings for SVRA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies MIRM News SDGR News MTSR News BHVN News BLTE News NAMS News AAPG News SUPN News JANX News ARWR News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SVRA) was last updated on 4/18/2025 by MarketBeat.com Staff From Our PartnersCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredDOGE tax surpriseElon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax auth...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Savara Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Savara With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SVRA Stock Free SVRA Stock Alerts